Latest Articles

Publication Date
Clinical efficacy and safety of Chinese patent medicines combined with hormonal therapy for endometriosis after laparoscopic surgery: A Bayesian network meta-analysis.

Chinese patent medicines (CPMs), standardized herbal formulations widely used in clinical practice, combined with hormones have shown favorable therapeutic effects in the adjuvant treatment of endometriosis (EMS) after laparoscopic surgery. …

Published: Sept. 6, 2025, midnight
Dysfunction of natural killer cells promotes immune escape and disease progression in endometriosis.

Endometriosis (EMs) is a chronic inflammatory disorder characterized by dysregulated innate immunity, particularly impaired cytotoxic function of natural killer (NK) cells. As pivotal effectors of the innate immune response, NK …

Published: Sept. 5, 2025, midnight
From First Breathless Episode to Final Diagnosis and Treatment: A Case Report on Thoracic Endometriosis Syndrome.

Background: Endometriosis is a chronic disease defined by the presence of endometrial-like tissue outside the uterine cavity. While typically confined to the pelvis, extrapelvic manifestations-including thoracic endometriosis-can occur. Although rare, …

Published: Sept. 4, 2025, midnight
New Illinois law restricts the use of AI in psychotherapy - marketplace.org

New Illinois law restricts the use of AI in psychotherapy marketplace.org

Published: Sept. 2, 2025, 3:15 p.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider - SINA HONG KONG LIMITED

Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider SINA HONG KONG LIMITED

Published: Sept. 2, 2025, 11:40 a.m.
Endometriosis and menopausal health: An EMAS clinical guide.

Endometriosis is a common gynecological condition, and problems may persist or develop after the menopause. Endometriosis or its treatment in premenopausal women may lead to premature or early menopause. Thus, …

Published: Sept. 2, 2025, midnight
Stem Cell Therapy: Revolutionizing Women’s Reproductive Health - BIOENGINEER.ORG

Stem Cell Therapy: Revolutionizing Women’s Reproductive Health BIOENGINEER.ORG

Published: Aug. 30, 2025, 7:33 a.m.
Menstrual blood-derived endometrial stem cells ameliorate neuroinflammation and apoptosis through JAK2/STAT3 signaling pathway in NPC1 mutant cell and mice - Stem Cell Research & Therapy

Menstrual blood-derived endometrial stem cells ameliorate neuroinflammation and apoptosis through JAK2/STAT3 signaling pathway in NPC1 mutant cell and mice Stem Cell Research & Therapy

Published: Aug. 29, 2025, 1:47 a.m.
Neuroinflammation is responsible for pain in endometriosis - targeting the JAK-STAT pathway and mast cell activation.

Chronic pain is a defining feature of endometriosis and contributes significantly to the diminished quality of life observed in affected individuals. Despite advances in understanding disease pathology, current therapeutic strategies …

Published: Aug. 29, 2025, midnight
Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. - AInvest

Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. AInvest

Published: Aug. 28, 2025, 8:24 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!